comprises fulvestrant in solution, 30% or less weight of a pharmaceutically acceptable alcohol per volume of formulation, at least
1% weight of a pharmaceutically-acceptable non-aqueous ester
solvent miscible in a ricinoleate vehicle per volume of formulation and a sufficient amount of a ricinoleate vehicle so as to

Seite 5
O2015_012